Journal Information
Vol. 38. Issue 3.
Pages 231 (March 2019)
Recommended Article of the Month
Open Access
Brief Comment Video to the Recommended Article of the Month
Breve Comentário Vídeo ao Artigo Recomendado do Mês
Visits
3069
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Thomas A. Zelniker, Stephan D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Remo H. M. Furtado, Deepak L. Bahatt, Lawrence A. Leiter, Darren K. McGuire, John P. H. Wilding, Marc S. Sabatine (in Lancet 2019;393:31-39)

Entrevistada: Cristina Gavina

Entrevistador: Ricardo Fontes-Carvalho

Link: https://www.youtube.com/watch?v=IeUqwbhKVm0&list=PL-uOq5lzrAwa8yYWWoJ9RQphZyY3DVyEx∈dex=12

Conflicts of interest

The authors have no conflicts of interest to declare.

Please cite this article as: en. Brief Comment Video to the Recommended Article of the Month. Rev Port Cardiol. 2019;38:231.

Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos